Sarepta Therapeutics (SRPT) Shares Outstanding (Diluted Average) (2010 - 2025)

Sarepta Therapeutics' Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $100.1 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) fell 7.19% year-over-year to $100.1 million; the TTM figure through Dec 2025 stood at $100.1 million (down 7.19% YoY), while the FY2025 annual figure was $100.1 million, down 7.19% from the prior year.
• Shares Outstanding (Diluted Average) was $100.1 million for Q4 2025 at Sarepta Therapeutics, up from $98.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $107.9 million in Q4 2024 to a low of $88.6 million in Q3 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $98.0 million across 3 years, with a median of $99.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) increased 16.75% in 2024, then decreased 7.19% in 2025.
• A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $92.4 million in 2023, then rose by 16.75% to $107.9 million in 2024, then decreased by 7.19% to $100.1 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $100.1 million (Q4 2025), $98.5 million (Q3 2025), and $106.6 million (Q2 2025), per Business Quant data.